How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
about
Mechanisms of disease reversal in focal and segmental glomerulosclerosisEfficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trialsNovel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designTubular overexpression of gremlin induces renal damage susceptibility in mice.Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.Increased renal versican expression is associated with progression of chronic kidney disease.Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosisGlycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.Kidney function can improve in patients with hypertensive CKDSalvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in ratsPreventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Role of remission clinics in the longitudinal treatment of CKD.Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney diseaseTherapeutic potential of TGF-beta inhibition in chronic renal failure.PAI-1 and kidney fibrosis.Latest treatment strategies for membranous nephropathy.Genetic Considerations in Pediatric Chronic Kidney Disease.Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.Which antihypertensive drugs are the most nephroprotective and why?Role of dyslipidemia in patients with chronic kidney disease.Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression.The role of renin angiotensin system inhibition in kidney repair.High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes.Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment.Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation.Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin.Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial.Pitavastatin suppresses hyperglycaemia-induced podocyte injury via bone morphogenetic protein-7 preservation.Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney.Kidney regeneration in mammals.A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort studyTherapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives
P2860
Q27010135-B457A034-6344-4805-AEC9-983CD7BE8A13Q28068027-6A7792F3-BD66-4D96-993C-D2960326A91BQ33817568-8C6B42F3-4F25-41E3-A7D2-BEBA9707DF6FQ33921130-3111D587-90FE-42A2-9EF9-BB08509F0FD0Q34405404-3677D6B3-0838-474E-BB9A-DA95E8DEF5C8Q34425104-20B10B15-BD74-4689-A861-497DFA584B2BQ34805601-49314B14-35F0-4BDF-AC9A-C3FC9717F2FDQ35121215-BFA0F533-BFE1-4D52-8A91-79AE708AA18CQ35853283-958CBD7A-4497-4554-B57A-309CE98D29E7Q35869192-45F03399-111D-4C5F-BA73-3119235E4EF1Q36392987-0109BE80-4B1D-43D3-8F73-9752AA39871CQ36577189-8CEA48BF-0B23-47D0-9C07-EF5465B6CAE2Q36677647-D8AFC15A-3A33-45B2-B366-FA0E0BDE0235Q36700001-12A0104E-0F33-4D07-8318-0A61E1B8CA95Q36739752-6A253611-62EC-49FE-9756-11AA20F23EF7Q36846526-89CB87DA-00DF-4455-AACE-EE909E928FAAQ37013035-26E95550-C3B6-474A-95A2-EA965268D2ECQ37032679-B30F6A7B-A499-4BAE-9342-481845FD9251Q37247753-22521934-F5D8-4AE5-889C-4288869D4AD7Q37803235-1F4B686D-B709-45EE-B76A-91AE52FE0BDEQ38120646-AD7ED83B-0411-401B-9C2F-FEAA27CF659BQ38704835-46547255-5329-47C5-91AE-B54AA568C14EQ41206891-22ADC1DB-76B1-435A-9036-7088CBC873A5Q41807679-C706A91D-DCDE-4208-BBD1-57D8AFEEBCC5Q42448757-D0A1F622-601A-4152-9B64-9CB4B079916DQ42933669-9A5FB674-B013-43D3-80F5-56DA961A8CDDQ43295208-E2542A15-F67E-482F-9E84-C180DDE0BFA1Q43456104-B6CE952B-63C0-4A58-8148-F007E0EB6A00Q44407942-88E5D4F7-9F6F-488F-B620-2DFEFC75A5E0Q45275121-5256B545-AAAC-4E7E-A673-B74186C7D76BQ46563865-7BD53A43-E738-4250-9B35-F37B56A53D0CQ47270697-F4E288CC-697C-4750-AD09-E2C53684C781Q50440958-D27B5491-6A62-4193-A3E0-740D9ED1BC97Q50873297-D6B5E809-49F6-44D3-9A47-17923D72F9C4Q51247990-BAE3CA3B-7BDF-4F5D-9C5D-25C0659CB135Q53197248-09657148-B2B8-4232-8587-01CC292C96DDQ54478096-79EFBE4E-6A2B-4B4F-B031-4E09C17A20C8Q55210136-7233CDD6-2164-48B0-B4BB-0F5488CF383CQ57701511-1162CE6B-B98F-4EA0-8DAA-CD992341E52CQ57703131-B189C849-CB17-427F-ABB8-693490C11C8D
P2860
How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
How to fully protect the kidne ...... ropathy: a multidrug approach.
@en
type
label
How to fully protect the kidne ...... ropathy: a multidrug approach.
@en
prefLabel
How to fully protect the kidne ...... ropathy: a multidrug approach.
@en
P2093
P1476
How to fully protect the kidne ...... ropathy: a multidrug approach.
@en
P2093
Carla Zoja
Cristian Batani
Cristina Zanchi
Daniela Corna
Daniela Rottoli
Davide Camozzi
Mauro Abbate
P304
P356
10.1097/01.ASN.0000034912.55186.EC
P577
2002-12-01T00:00:00Z